首页 | 本学科首页   官方微博 | 高级检索  
     

脾虚证模型大鼠血清中血管活性肠肽和胆囊收缩素的变化及四君子汤的干预作用
引用本文:张海燕,陈君千,张望,黄绍刚,黄穗平. 脾虚证模型大鼠血清中血管活性肠肽和胆囊收缩素的变化及四君子汤的干预作用[J]. 吉林中医药, 2014, 0(6): 609-611
作者姓名:张海燕  陈君千  张望  黄绍刚  黄穗平
作者单位:[1]广东省中医院,广州510120 [2]广州中医药大学,广州510405
基金项目:广东省中医药局资助“四君子汤对胃肠平滑肌细胞肌球蛋白轻链激酶(MLCK)表达的影响”(20122139); 广州中医药大学中医内科学特色重点学科建设项目(广州中医药大学资助)
摘    要:目的研究脾虚证模型大鼠血清中血管活性肠肽(VIP)和胆囊收缩素(CCK)的变化以及四君子汤的干预作用,探讨四君子汤调节大鼠胃肠动力的机制。方法采用饥饱失常加劳倦加破气耗气方法复制脾虚大鼠模型,将60只大鼠随机分为正常组、模型组、四君子汤组、莫沙必利组,用Elisa法测定每组大鼠血清中血管活性肠肽和胆囊收缩素的含量。结果模型组大鼠血清中血管活性肠肽含量(28.60±41.88)明显减少,与正常组(51.55±16.22)比较差异具有统计学意义(P<0.05);模型组大鼠血清中胆囊收缩素(3.55±2.53)含量明显升高,与正常组(2.05±0.67)比较差异具有统计学意义(P<0.05)。经治疗后,四君子汤组大鼠血清中血管活性肠肽(57.51±13.25)、莫沙必利组大鼠血清中血管活性肠肽(61.63±27.46)均较模型组显著升高(P<0.05),四君子汤组大鼠血清胆囊收缩素(2.29±0.81)较模型组显著降低(P<0.05)。结论四君子汤能调节脾虚证大鼠的胃肠激素,从而纠正其胃肠功能紊乱,这是四君子汤治疗脾虚证的作用机制之一。

关 键 词:脾虚证  血管活性肠肽(VIP)  胆囊收缩素(CCK)  四君子汤  大鼠

Vasoactive intestinal peptide and cholecystokinin in serum of rat spleen deficiency model and the intervention effect of Sijunzi Decoction
ZHANG Haiyan,CHEN Junqian,ZHANG Wang,HUANG Shaogang,HUANG Suiping. Vasoactive intestinal peptide and cholecystokinin in serum of rat spleen deficiency model and the intervention effect of Sijunzi Decoction[J]. Jilin Journal of Traditional Chinese Medicine, 2014, 0(6): 609-611
Authors:ZHANG Haiyan  CHEN Junqian  ZHANG Wang  HUANG Shaogang  HUANG Suiping
Affiliation:1. Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China; 2. Guangzhou university of Chinese Medicine, Guangzhou 510405, China)
Abstract:Objective To investigate the changes of vasoactive intestinal peptide( VIP) and cholecystokinin( CCK) in serum of rat spleen deficiency model and intervention effect of sijunzi decoction,to explore the mechanism of gastrointestinal motor. Methods The rat model of spleen deficiency were established,and all the rats were divided randomly into four groups as following,the normal,model,sijunzi decoction and Mosapride. And the contents of VIP and CCK in serum of rats were measured with Elisa kit. Results The contents of VIP( 28. 60 ± 41. 88) in rats serum of model group decreased evidently,compared with the normal group( 51. 55 ± 16. 22),the difference was statistically significant( P〈0.05). The contents of CCK( 3. 55 ± 2. 53) increased evidently in rats serum of model group,compared with the normal group( 2. 05 ± 0. 67),the difference was statistically significant( P〈0. 05). After the treatment,the contents of VIP(57.51 ±13.25) in rats serum of sijunzi decoction group were higher than that in model group( P0.05),the contents of VIP( 61. 63 ±27. 46) in rats serum of Mosapride group were also higher than that in model group( P〈0. 05). The contents of CCK( 2. 29 ±0. 81) inrats serum of sijunzi decoction group were lower than that in model group( P〈0. 05). Conclusion The sijunzi decoction could regulate the gastrointestinal hormone of spleen deficiency rats,so as to correct tstomach and intestinal disorders,which was one of the mechanisms of sijunzi decoction treating spleen deficiency syndrome.
Keywords:Spleen deficiency  Vasoactive intestinal peptide(VIP)  Cholecystokinin(CCK)  Sijunzi Decoction  mouse
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号